<?xml version="1.0" encoding="UTF-8"?>
<p>The position of the industrial partner in the Dutch EUPATI network deserves further consideration. All stakeholders regard the pharmaceutical industry as both a relevant and an essential partner for the Dutch EUPATI course. Combining knowledge and resources in order to address the challenges of pharmaceutical innovation has been proved to be beneficial for government organizations, the academic world, patient organizations, health foundations, and the pharmaceutical industry, as they all share that interest (
 <xref rid="B14" ref-type="bibr">14</xref>). As involvement of an industrial partner is prone to be affected by a negative public image (
 <xref rid="B21" ref-type="bibr">21</xref>, 
 <xref rid="B22" ref-type="bibr">22</xref>), careful deliberation is crucial to avoid a negative impact on the credibility of the training program. Combining the recommendations of several stakeholders in this regard, together with the available international and other guidelines on collaboration with the industry (
 <xref rid="B5" ref-type="bibr">5</xref>) will let us establish an internationally accepted modus operandi, customized for the Dutch situation. Trust, alignment of goals, balancing power, and open communication are among the underlying concepts to be considered (
 <xref rid="B9" ref-type="bibr">9</xref>, 
 <xref rid="B17" ref-type="bibr">17</xref>, 
 <xref rid="B18" ref-type="bibr">18</xref>).
</p>
